---
title: "EAGLERISE (CHINA) has received approval from the Securities Regulatory Commission for its application to issue stocks to specific entities"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249771767.md"
description: "According to the Zhitong Finance APP, EAGLERISE (CHINA) announced that on July 23, 2025, it received the \"Approval on EAGLERISE Electric Co., Ltd. for the Registration of Stock Issuance to Specific Objects\" (CSRC Permit [2025] No. 1509) issued by the China Securities Regulatory Commission, approving the company's application for stock issuance registration to specific objects"
datetime: "2025-07-23T12:24:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249771767.md)
  - [en](https://longbridge.com/en/news/249771767.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249771767.md)
generator: "portal-rs"
---

# EAGLERISE (CHINA) has received approval from the Securities Regulatory Commission for its application to issue stocks to specific entities

According to the Zhitong Finance APP, EAGLERISE (CHINA) (002922.SZ) announced that on July 23, 2025, it received the "Approval on EAGLERISE Electric Co., Ltd. to Issue Stocks to Specific Objects" issued by the China Securities Regulatory Commission (CSRC) (Zheng Jian Xu Ke \[2025\] No. 1509), approving the company's application for stock issuance registration to specific objects

### Related Stocks

- [002922.CN](https://longbridge.com/en/quote/002922.CN.md)

## Related News & Research

- [BYD launches Sealion 08 SUV, bolstering Ocean lineup's flagship push](https://longbridge.com/en/news/297765654.md)
- [Discovery FY26 profit attributable to ordinary shareholders climbs 39% to R13.13 billion](https://longbridge.com/en/news/297867897.md)
- [Motus FY26 earnings per share rise 19% to 1,753 cents; revenue climbs 1% to ZAR 113.55 billion](https://longbridge.com/en/news/297734398.md)
- [US says no ships hit mines in Strait of Hormuz](https://longbridge.com/en/news/297523587.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**